AUTHOR=Sun Yongcheng , Wang Tao , Wang Shuyan , Chen Yan , Xu Zhijuan , Shi Cong , Wang Zanzan , Ouyang Guifang 

TITLE=Novel compound heterozygous PIEZO1 variants in dehydrated hereditary stomatocytosis initially suspected as myelodysplastic syndromes: a case report

JOURNAL=Frontiers in Oncology

VOLUME=Volume 15 - 2025

YEAR=2025

URL=https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2025.1574518

DOI=10.3389/fonc.2025.1574518

ISSN=2234-943X

ABSTRACT=IntroductionDehydrated hereditary stomatocytosis (DHS) is a rare autosomal dominant congenital non-immune hemolytic anemia caused by pathogenic variants in the PIEZO1 gene. Its clinical presentation often overlaps with other hematological disorders, leading to diagnostic challenges and potential mismanagement.Case presentationA 22-year-old man presented with a 7-year history of anemia initially misdiagnosed as myelodysplastic syndrome (MDS) due to hypercellular bone marrow findings and MDS-like features. Over time, his condition progressed to include cerebral venous sinus thrombosis (CVST), a severe complication. Comprehensive genetic testing at our hospital using whole-exome sequencing (WES) revealed novel compound heterozygous PIEZO1 variants: NM_001142864.4: c.6622A>G (p.Ile2208Val) and NM_001142864.4: c.3160C>A (p.Leu1054Met). These findings confirmed the diagnosis of DHS. The patient underwent allogeneic hematopoietic stem cell transplantation (allo-HSCT), resulting in resolution of his hematological abnormalities and symptoms.ConclusionThis case underscores the importance of considering DHS in patients with unexplained anemia and MDS-like features, particularly when associated with thrombotic complications. It highlights the critical role of genetic testing in diagnosing rare hereditary anemias and demonstrates that allo-HSCT can be a curative treatment in selected cases.